This title discusses all aspects of non-infectious and non-cancer-
so called NINC - vaccines. Hypertension, diabetes and allergy
vaccine development are referred to as well as the use of adjuvants
and nanotechnology in vaccine development. The way of novel
vaccines from bench to preclinical to clinical studies and launch
to the market under EMEA (European Medicines Agency) and FDA (Food
and Drug Administration) guidelines are described in-depth. The
book is therefore of interest for researchers and clinicians
engaged in vaccine development and molecular vaccine application.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!